Technology in human trials to spot cardiac disease, cancer, drug abuse
February 10th, 2011 - 7:21 pm ICT by ANIWashington, Feb 10 (ANI): Rice University scientists have come up with a new microchip technology, which is expected to advance the art of diagnosis.
Cardiac disease is the focus of one of six ongoing major clinical trials of Rice’s programmable bio-nano-chips (PBNCs).
PBNCs combine microfluidics, nanotechnology, advanced optics and electronics to enable quick, painless diagnostic tests for a wide range of diseases at minimal cost.
Current clinical trials employ PBNCs to test more than 4,000 patients for signs of heart disease, ovarian cancer, prostate cancer, oral cancer and drug abuse. Versions to test for HIV/AIDS and other diseases are also in development.
“Too often, the first time people know they’re suffering from heart disease is when it kills them,” said John McDevitt, Rice’s Brown-Wiess Professor of Chemistry and Bioengineering.
“With this test, we expect to save lives and dramatically cut the recovery time and cost of caring for those who suffer from heart ailments,” said McDevitt, a pioneer in the creation of microfluidic devices for biomedical testing.
PBNCs analyze a patient’s saliva for biomarkers associated with cardiovascular disease.
PBNCs now in development deliver results in as little as 20 minutes and provide clinicians with timely information that can help them manage patients more effectively.
McDevitt will discuss the potential of this technology at the annual meeting of the American Association for the Advancement of Science (AAAS) in Washington, D.C., Feb. 17-21. (ANI)
- Microsponges from seaweed may help diagnose diseases quickly - Feb 10, 2011
- West Virginia doctor pleads guilty for allowing illegal distribution of diet drug - Jan 21, 2010
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- London hospital to do Europe's first embryonic stem cell trial - Sep 24, 2011
- New tool for early detection of ovarian cancer - May 21, 2010
- Drug discovery combats ovarian cancer - Jun 05, 2011
- 'Smart' new drug shows promise in ovarian cancer - Nov 09, 2010
- Reducing time to diagnosis of ovarian cancer may not improve outcome - May 04, 2011
- New discovery may help in the fight against ovarian cancer - Feb 04, 2011
- New genetic marker of ovarian cancer risk discovered - Jul 21, 2010
- New technique to identify potential atherosclerosis risk found - Apr 12, 2011
- New drug shows promise against platinum resistant ovarian cancer - Oct 10, 2010
- Avastin helps women who are suffering from ovarian cancer - Oct 12, 2010
- Breast cancer campaign 'diverting attention' - Jan 09, 2011
- Prostate cancer screening improves patients' quality of life - Oct 26, 2010
Tags: advanced optics, american association for the advancement of science, american association for the advancement of science aaa, bioengineering, biomarkers, cancer drug, cancer prostate, cardiac disease, heart ailments, hiv aids, john mcdevitt, microchip technology, microfluidic devices, oral cancer, ovarian cancer, prostate cancer, rice university scientists, s brown, signs of heart disease, wiess